The best indicator for Regeneron Pharmaceuticals (REGN)
We backtested 382 indicators across daily, weekly and hourly charts on real Regeneron Pharmaceuticals (REGN) history. Here's what actually worked — risk-adjusted over the full backtest, with costs, and checked out-of-sample.
Where Regeneron Pharmaceuticals (REGN) stands
Computed from our own daily OHLCV history, not quoted from a third party. Moving averages use closing prices; "52-week" is the last 252 trading sessions.
Ultimate Oscillator
On the daily chart, this is the strongest risk-adjusted edge we found for Regeneron Pharmaceuticals (REGN) over ~35.5 years — beating buy-and-hold by 7.3% CAGR.
Regeneron Pharmaceuticals (REGN) on the daily chart
The timeframe our backtest found best for this asset. The chart is live market data; the results above are hypothetical and historical.
Chart by TradingView. Loading it contacts tradingview.com, which may set its own cookies — see our privacy policy.
Best multi-indicator combo
Going long only when all 3 agree was the strongest confluence setup we found for Regeneron Pharmaceuticals (REGN) — trailing buy-and-hold by 5.0% CAGR, out-of-sample. Fewer, higher-conviction trades than any single indicator.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Ultimate Oscillator ✓ | Daily | 17.9% | 0.58 | -82.6% | 79.5% | 39 | 7.3% |
| 2 | SMC: Change of Character ✓ | Daily | 12.9% | 0.49 | -87.8% | 50.0% | 90 | 2.3% |
| 3 | Heikin-Ashi Trend | Weekly | 14.2% | 0.49 | -60.9% | 43.8% | 336 | 3.0% |
| 4 | Ehlers Relative Vigor ✓ | Daily | 12.7% | 0.48 | -78.9% | 42.8% | 768 | 2.1% |
| 5 | Intraday Momentum Index ✓ | Weekly | 11.9% | 0.48 | -69.4% | 66.7% | 21 | 0.8% |
| 6 | McGinley 100 Trend ✓ | Daily | 11.1% | 0.47 | -91.3% | 30.6% | 36 | 0.5% |
| 7 | HMA 9/21 Cross ✓ | Weekly | 12.5% | 0.47 | -73.9% | 50.8% | 118 | 1.3% |
| 8 | Holy Grail Confluence ✓ | Daily | 10.3% | 0.46 | -66.5% | 75.0% | 60 | -0.3% |
| 9 | McGinley 200 Trend ✓ | Daily | 10.3% | 0.46 | -93.7% | 23.1% | 26 | -0.3% |
| 10 | Stochastic (20,5) ✓ | Daily | 11.5% | 0.46 | -86.9% | 43.2% | 653 | 0.9% |
| 11 | McGinley Dynamic ✓ | Weekly | 11.3% | 0.46 | -88.0% | 30.4% | 23 | 0.2% |
| 12 | Chande Forecast Osc. | Weekly | 12.4% | 0.46 | -70.1% | 53.4% | 206 | 1.3% |
| 13 | Bollinger Mean-Reversion | Daily | 9.6% | 0.45 | -60.8% | 68.2% | 151 | -1.0% |
| 14 | Fisher Transform ✓ | Daily | 11.4% | 0.45 | -89.9% | 43.2% | 850 | 0.7% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
What it would take to beat buy & hold on Regeneron Pharmaceuticals (REGN)
252 of 685 tested setups beat buy-and-hold on Regeneron Pharmaceuticals (REGN) outright. Another 25 could get there with leverage they would survive — but 14 would be liquidated by their own drawdown before they caught it.
| Indicator | Beats B&H unlevered | Leverage needed | Leverage survived |
|---|---|---|---|
| EMA 8/21 Cross | 2 | none needed | 2.18× |
| DEMA 20/50 Cross | 2 | none needed | 2.96× |
| Sine-Weighted MA | 2 | none needed | 2.21× |
| Vertical Horizontal Filter | 2 | none needed | 3.76× |
| Impulse MACD | 2 | none needed | 2.91× |
| CMO (21) | 2 | none needed | 2.33× |
Out-of-sample, costs included. A setup is only listed if the leverage it needs is less than the leverage its own worst drawdown survives — when it isn't, no amount of leverage gets there. Volatility drag isn't modelled, so these are the optimistic case. Every indicator, ranked this way
For Regeneron Pharmaceuticals (REGN), Ultimate Oscillator on the daily timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get alerted when Regeneron Pharmaceuticals’s signal flips
We track Regeneron Pharmaceuticals daily. Its backtested best indicator, Ultimate Oscillator (Daily), is flat right now — we'll email you the moment that changes. Free, no spam, unsubscribe any time.